Effects of nociceptin on the spread and seizure activity in the rat amygdala kindling model: Their correlations with 3H-leucyl-nociceptin binding

Epilepsy Research

Volumn 77, Issue 2-3, 2007, Pages 75-84

  Carmona Aparicio, Liliana ^a   Peña, Fernando ^a   Borsodi, Anna ^b   Rocha, Luisa ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Afterdischarge threshold; Kindling; Nociceptin; Nociceptin receptor; Postictal depression

Indexed keywords

H 3 LEUCYLNOCICEPTIN; NALOXONE; NEUROPEPTIDE; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR CHANGE; CENTRAL GRAY MATTER; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ENTORHINAL CORTEX; FOCAL EPILEPSY; FRONTAL CORTEX; GRAND MAL SEIZURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RECEPTOR BINDING; SUBSTANTIA NIGRA;

AMYGDALA; ANIMALS; BRAIN; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; INJECTIONS, INTRAVENTRICULAR; KINDLING, NEUROLOGIC; MALE; OPIOID PEPTIDES; RATS; RATS, WISTAR; SEIZURES;

EID: 36248972286     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2007.08.007     Document Type: Article

References (46)

1. Ackermann R.F., Chugani H.T., Handforth A., Moshé S., Caldecott-Hazard S., and Engel J.J. Autoradiographic studies of cerebral metabolism and blood flow in rat amygdala kindling. In: Wada J.A. (Ed). Kindling vol. 3 (1986), Raven Press, New York 73-87
2. Aparicio L.C., Candeletti S., Binashi A., Mazzuferri M., Di Benedetto M., Landuzzi D., Romualdi P., and Simonato M. Kainate seizures increase Nociceptin/Orphanin FQ release in the rat hippocampus and thalamus: a microdialysis study. J. Neurochem. 91 (2004) 30-37
3. Bertorelli R., Corradini L., Rafiq K., Tupper J., Calo G., and Ongini E. Nociceptin and the ORL-1 ligand [Phe1psi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain. Br. J. Pharmacol. 128 (1999) 1252-1258
4. Binaschi A., Zucchini S., Bregola G., Rodi D., Mazzuferi M., Reinscheid R.K., and Simonato M. Delayed epileptogenesis in Nociceptin/Orphanin FQ deficient mice. Neuroreport 14 (2003) 825-827
5. Bregola G., Candeletti S., Romualdi P., and Simonato M. Limbic seizures increase pronociceptin mRNA levels in the thalamic reticular nucleus. Neuroreport 10 (1999) 541-546
6. Bregola G., Zucchini S., Frigati L., Candeletti S., Romualdi P., Reinscheid R., and Simonato M. Involvement of the Neuropeptide Orphanin FQ/Nociceptin in kainate and kindling seizures and epileptogenesis. Epilepsia 43 (2002) 18-19
7. Bregola G., Zucchini S., Rodi D., Binaschi A., D'Addario C., Landuzzi D., Reinscheid R., Candeletti S., Romualdi P., and Simonato M. Involvement of the neuropeptide Nociceptin/Orphanin FQ in kainate seizures. J. Neurosci. 22 (2002) 10030-10038
8. Calo G., Rizzi A., Marzola G., Guerrini R., Salvadori S., Beani L., Regoli D., and Bianchi C. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol. 125 (1998) 373-378
9. 2, a new selective nociceptin receptor antagonist. Br. J. Pharmacol. 129 (2000) 1183-1193
10. Chiou L.C., Liao Y.Y., Fan P.C., Kuo P.H., Wang C.H., Riemer C., and Prinssen E.P. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr. Drug Targets 8 (2007) 117-135
11. Clarke S., Chen Z., Hsu M.S., Pintar J., Hill R., and Kitchen I. Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene. Brain Res. 906 (2001) 13-24
12. Engel J.J., and Ackermann R.F. Interictal EEG spikes correlate with decreased, rather than increased, epileptogenicity in amygdaloid kindled rats. Brain Res. 2 (1980) 543-548
13. Engel J.J., and Rocha L. Interictal behavioral disturbances: a search for molecular substrates. Epilepsy Res. 9 (1992) 341-350
14. Feng Y., Chao D.M., Li W.M., Cao Y.X., Wang Y.Q., and Wu G.C. Inhibition of nociceptin/orphanin FQ on penicillin-induced seizures in rats. Brain Res. 1020 (2004) 214-219
15. Fischer A., and Undem B.J. Naloxone blocks endomorphin-1 but not endomorphin-2 induced inhibition of tachykinergic contractions of guinea-pig isolated bronchus. Br. J. Pharmacol. 127 (1999) 605-608
16. Frenk H., Engel J.J., Ackermann R.F., Shavit Y., and Liebeskind J.C. Endogenous opioids may mediate post-ictal behavioral depression in amygdaloid-kindled rats. Brain Res. 167 (1979) 435-440
17. Grisel J.E., Mogil J.S., Belknap J.K., and Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport 7 (1996) 2125-2129
18. Gutierrez R., Leff P., Romo-Parra H., Acevedo R., and Antón B. Orphanin-FQ/Nociceptin inhibits kindling epileptogenesis and enhances hippocampal feed-forward inhibition. Neuroscience 105 (2001) 325-333
19. Hashimoto Y., Calo G., Guerrini R., Smith G., and Lambert D.G. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors. Eur. J. Pharmacol. 449 (2002) 17-22
20. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma F.J.J., Nothacker H.P., and Civelli O. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14854-14858
21. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.L., Ouagazzal A.M., Martin J.R., Lundstrom K., Cesura A.M., Poli S.M., Roever S., Kolczewski S., Adam G., and Kilpatrick G. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4938-4943
22. Kest B., Hopkins E., Palmese C.A., Chen Z.P., Mogil J.S., and Pintar J.E. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice. Neuroscience 104 (2001) 217-222
23. Löscher W., Cramer S., and Ebert U. Limbic epileptogenesis alters the anticonvulsant efficacy of phenytoin in Sprague-Dawley rats. Epilepsy Res. 31 (1998) 175-186
24. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., Noda T., Takahashi T., Sugimoto T., Nabeshima T., and Takeshima H. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394 (1998) 577-581
25. Mathis J.P., Goldberg I.E., Rossi G.C., Leventhal L., and Pasternak G.W. Antinociceptive analogs of orphanin FQ/nociceptin(1-11). Life Sci. 63 (1998) 161-166
26. Mathis J.P., Goldberg I.E., Letchworth S.R., Ryan-Moro J.P., and Pasternak G.W. Identification of a high-affinity orphanin FQ/nociceptin(1-11) binding site in mouse brain. Synapse 34 (1999) 181-186
27. 1 receptor. Nature 377 (1995) 532-535
28. Mitsushima D., Funabashi T., and Kimura F. Fos expression in gonadotropin-releasing hormone neurons by naloxone or bicuculline in intact male rats. Brain Res. 839 (1999) 209-212
29. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., and Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75 (1996) 333-337
30. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., and Grandy D.K. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci. Lett. 214 (1996) 131-134
31. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev. 53 (2001) 381-415
32. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., Caput D., Vassart G., and Meunier J.C. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341 (1994) 33-38
33. Neal C.R.J., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., and Watson S.J.J. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J. Comp. Neurol. 412 (1999) 563-605
34. Nobrega J.N., Kish S.J., and Burnham W.M. Autoradiographic analysis of benzodiazepine binding in entorhinal-kindled rat brains. Brain Res. 498 (1989) 315-322
35. Ouagazzal A.M., Moreau J.L., Pauly-Evers M., and Jenck F. Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/orphanin FQ peptide precursor gene. Behav. Brain Res. 144 (2003) 11-17
36. Ozsoy H.Z., Thakker D.R., and Standifer K.M. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation. Mol. Pharmacol. 68 (2005) 447-456
37. Pan Y.X., Xu J., Wan B.L., Zuckerman A., and Pasternak G.W. Identification and differential regional expression of KOR-3/ORL-1 gene splice variants in mouse brain. FEBS Lett. 435 (1998) 65-68
38. Pan Z., Hirakawa N., and Fields H.L. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 26 (2000) 515-522
39. Paxinos G., and Watson C. The Rat Brain in Stereoctaxic Coordinates. fourth ed. (1998), Academic Press, USA
40. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
41. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J.J., and Civelli O. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science 270 (1995) 792-794
42. Rocha L., Ackermann R.F., and Engel J.J. Effects of chronic morphine pretreatment on amygdala kindling development, postictal seizure and suppression and benzodiazepine receptor binding in rats. Epilepsy Res. 23 (1996) 225-233
43. Rubaj A., Zgodzinski W., Gustaw K., and Sieklucka-Dziuba M. Nociceptin, OP4 receptor ligand in different models of experimental epilepsy. Peptides 23 (2002) 497-505
44. Shin C., Pedersen H.B., and McNamara J.O. Gamma-aminobutyric acid and benzodiazepine receptors in the kindling model of epilepsy: a quantitative radiohistochemical study. Neuroscience 5 (1985) 2696-2701
45. Wang H.L. A conserved arginine in the distal third intracellular loop of the mu-opioid receptor is required for G protein activation. J. Neurochem. 72 (1999) 1307-1314
46. Wang H.L., Hsu C.Y., Huang P.C., Kuo Y.L., Li A.H., Yeh T.H., Tso A.S., and Chen Y.L. Heterodimerization of opioid receptor-like 1 and mu-opioid receptors impairs the potency of micro receptor agonist. J. Neurochem. 92 (2005) 1285-1294